Psyence Biomedical (PBM) Interest & Investment Income (2025)

Psyence Biomedical (PBM) posted quarterly Interest & Investment Income of $72815.0 for Q3 2025.

Psyence Biomedical (PBM) Interest & Investment Income (2025) Analysis & Trends

Psyence Biomedical (PBM) has reported Interest & Investment Income for 1 consecutive years, with $72815.0 the latest figure, recorded in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn 44.00 Mn
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - -
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 27.66 Mn
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 114.80 Mn
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn -
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn -
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 44.00 Mn
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 26.60 Mn
9 Revolution Medicines 37.15 Bn 37.15 Bn - 19.51 Mn
10 Psyence Biomedical 1.72 Mn 1.72 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 72,815.00